Skip to main content
. 2014 Sep 18;111(11):2046–2050. doi: 10.1038/bjc.2014.502

Figure 2.

Figure 2

The median progression-free survival of all patients was 4 months (95% CI 2 months to 17 months).

HHS Vulnerability Disclosure